MannKind | MNKD - Net Income

Stock Price
3.52
Daily Change
-2.03 -36.55%
Monthly
-37.01%
Yearly
-35.74%
Q1 Forecast
5.37

MannKind reported $668K in Net Income for its fiscal quarter ending in June of 2025.





Net Income Change Date
Adma Biologics USD 36.43M 2.21M Sep/2025
BioCryst Pharmaceuticals USD -88.88M 74.85M Dec/2024
Eli Lilly USD 6.64B 1.05B Dec/2025
Halozyme Therapeutics USD -141.59M 316.82M Dec/2025
Insmed USD -328.48M 41.54M Dec/2025
Karyopharm Therapeutics USD -30.78M 1.29M Dec/2024
MacroGenics USD 16.82M 53.07M Sep/2025
MannKind USD 668K 12.49M Jun/2025
Merck USD 2.96B 2.82B Dec/2025
Minerva Neurosciences USD 1.44M 21.07M Dec/2024
Novavax USD -121.3M 283.68M Sep/2024
Novo Nordisk DKK 4.03B 25.01B Jun/2025
Pfizer USD -1.65B 5.19B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
Xencor USD -6.03M 24.8M Sep/2025